Ameritas Investment Partners, Inc. - AERIE PHARMACEUTICALS INC ownership

AERIE PHARMACEUTICALS INC's ticker is AERI and the CUSIP is 00771V108. A total of 140 filers reported holding AERIE PHARMACEUTICALS INC in Q3 2021. The put-call ratio across all filers is 0.59 and the average weighting 0.1%.

Quarter-by-quarter ownership
Ameritas Investment Partners, Inc. ownership history of AERIE PHARMACEUTICALS INC
ValueSharesWeighting
Q3 2022$56,000
+143.5%
3,728
+20.0%
0.00%
+200.0%
Q2 2022$23,000
-17.9%
3,1060.0%0.00%0.0%
Q1 2022$28,000
+27.3%
3,1060.0%0.00%0.0%
Q4 2021$22,000
-37.1%
3,1060.0%0.00%0.0%
Q3 2021$35,000
-30.0%
3,1060.0%0.00%
-50.0%
Q2 2021$50,000
-10.7%
3,1060.0%0.00%0.0%
Q1 2021$56,000
+14.3%
3,106
-13.9%
0.00%0.0%
Q4 2020$49,000
+16.7%
3,6060.0%0.00%0.0%
Q3 2020$42,000
-20.8%
3,6060.0%0.00%
-33.3%
Q2 2020$53,000
+8.2%
3,6060.0%0.00%0.0%
Q1 2020$49,000
-43.7%
3,6060.0%0.00%
-25.0%
Q4 2019$87,000
+26.1%
3,6060.0%0.00%
+33.3%
Q3 2019$69,000
-35.5%
3,6060.0%0.00%
-40.0%
Q2 2019$107,000
-24.1%
3,606
+21.7%
0.01%
-28.6%
Q1 2019$141,000
+31.8%
2,9640.0%0.01%
+16.7%
Q4 2018$107,000
-41.2%
2,9640.0%0.01%
-25.0%
Q3 2018$182,000
-9.0%
2,9640.0%0.01%
-20.0%
Q2 2018$200,000
+31.6%
2,964
+5.7%
0.01%
+42.9%
Q1 2018$152,000
-9.5%
2,8050.0%0.01%
-12.5%
Q4 2017$168,000
+10.5%
2,805
+5.3%
0.01%
+14.3%
Q3 2017$152,000
+8.6%
2,6650.0%0.01%0.0%
Q2 2017$140,000
+29.6%
2,665
+11.5%
0.01%
+40.0%
Q1 2017$108,0002,3900.01%
Other shareholders
AERIE PHARMACEUTICALS INC shareholders Q3 2021
NameSharesValueWeighting ↓
LEVIN CAPITAL STRATEGIES, L.P. 1,373,542$15,658,0001.56%
DAFNA Capital Management LLC 289,040$3,295,0000.87%
Integral Health Asset Management, LLC 250,000$2,850,0000.82%
JACOB ASSET MANAGEMENT OF NEW YORK LLC 193,266$2,203,0000.80%
PFM Health Sciences, LP 2,182,684$24,883,0000.73%
DCF Advisers, LLC 136,501$1,556,0000.69%
DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) 2,977,020$33,938,0000.66%
NEXPOINT ASSET MANAGEMENT, L.P. 309,778$3,532,0000.61%
Rhenman & Partners Asset Management AB 750,000$8,550,0000.60%
RICE HALL JAMES & ASSOCIATES, LLC 1,232,600$14,052,0000.52%
View complete list of AERIE PHARMACEUTICALS INC shareholders